Search clinical trials for: HER2 negative
Total 7743 results
-
Advaxis, Inc.CompletedHER2 Expressing Solid TumorsUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Bio-Thera SolutionsUnknownHER2-Positive Solid TumorsChina
-
Hoffmann-La RocheCompletedHER2-Positive Metastatic Breast Cancer | HER2-Negative Metastatic Breast Cancer | Locally Advanced or Early Breast CancerUnited States
-
Washington University School of MedicineWithdrawn
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Ludwig Institute for Cancer ResearchMie UniversityCompletedStomach Cancer | Breast Cancer | Esophageal Cancer | Ovarian Cancer | Lung CancerJapan
-
MedSIRAstraZeneca; Daiichi Sankyo, Inc.CompletedMetastatic Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerSpain
-
Iambic Therapeutics, IncRecruiting
-
Asan Medical CenterEisai Inc.; Dong-A ST Co., Ltd.; Samyang Biopharmaceuticals CorporationCompletedMetastatic Breast CancerKorea, Republic of
-
Ottawa Hospital Research InstituteCompleted
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; BayerActive, not recruitingEsophagogastric Cancer | HER2-NegativeUnited States
-
Heidelberg Pharma AGU.S. Army Medical Research and Development CommandCompletedMetastatic Breast CancerUnited States, Belgium, Brazil, Germany, Israel
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
Chinese PLA General HospitalFudan UniversityRecruitingHER2 Positive Advanced Solid TumorsChina
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingHER2-positive Advanced Solid TumorsChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
Peking UniversityRecruitingHER2 Positive Advanced Gastric CancerChina
-
Fudan UniversityRecruitingEffect of Drug | Gastrointestinal TumorChina
-
Fudan UniversityRecruitingLung Cancer, Non-small CellChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownHER2-positive Breast Cancer
-
Henan Cancer HospitalActive, not recruiting
-
Sun Yat-sen UniversityUnknown
-
The First Affiliated Hospital with Nanjing Medical...Completed
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7 | ERBB2 Gene AmplificationUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Advanced Solid TumorsChina
-
Hangzhou Adcoris Biopharmacy Co., LtdEnrolling by invitationHER2-positive Advanced Solid TumorChina
-
Chongqing University Cancer HospitalNot yet recruitingCervical Cancer | Ovarian Cancer | Endometrial Cancer | HER2 Expression
-
Applied Spectral Imaging Ltd.Completed
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdPeking UniversityCompletedHER2-positive Solid TumorsChina
-
MacroGenicsApproved for marketingHER2-positive Breast Cancer | HER2-positive Carcinoma
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
Seattle Children's HospitalActive, not recruitingGlioma | Ependymoma | Medulloblastoma | Pineoblastoma | Central Nervous System Tumor, Pediatric | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus CarcinomaUnited States
-
Michelle MeliskoTerminatedPhase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+Solid TumorUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Ovarian CancerUnited States
-
Triumvira Immunologics, Inc.Merck Sharp & Dohme LLCTerminatedHER2 Positive Gastric Cancer | Metastatic HER2 Positive Gastroesophageal Junction CancerUnited States, Canada
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative...United States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartisCompleted
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Consorzio OncotechCompleted
-
University of WashingtonNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | HER2/Neu PositiveUnited States
-
The Netherlands Cancer InstituteTesaro, Inc.TerminatedBreast CancerNetherlands